Storia in 16 fonti

AstraZeneca-Bristol Myers megamerger talk leaves Wall Street wanting more answers

The weekend report about a potential megamerger of AstraZeneca and Bristol Myers Squibb is raising a number of questions for both companies, according to biopharma analysts.

Raccontata da

cityam.com+4 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

endpoints.newsStai leggendo12 h fa

AstraZeneca-Bristol Myers megamerger talk leaves Wall Street wanting more answers

The weekend report about a potential megamerger of AstraZeneca and Bristol Myers Squibb is raising a number of questions for both companies, according to biopharma analysts.

originale

Timeline cronologica

domenica 2 agosto 2026·handelsblatt.com
Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb
Es wäre eine der größten Fusionen in der Wirtschaftsgeschichte. Laut einem Medienbericht wurden entsprechende Gespräche geführt. Ob es zu einem Zusammenschluss kommt ist jedoch…
domenica 2 agosto 2026·cnbc.com
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

AstraZeneca-Bristol Myers megamerger talk leaves Wall Street wanting more answers

Confronto fonti

AstraZeneca-Bristol Myers megamerger talk leaves Wall Street wanting more answers

Timeline cronologica

Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

Pharma giants AstraZeneca and Bristol-Myers in reported merger talks

AstraZeneca Stock Nosedives On Mega-Merger Rumor

AstraZeneca said to have explored Bristol Myers merger | Fortune

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca said to have explored Bristol Myers merger | Fortune

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

La potentielle fusion avec Bristol-Myers Squibb fait plonger AstraZeneca - Le Temps

Editor’s Corner: Why an AstraZeneca-Bristol Myers Squibb merger is a bad idea

Pharma: Astra-Zeneca erwägt wohl Mega-Fusion mit Bristol-Myers Squibb

AstraZeneca: Pharmakonzern prüft 400-Milliarden-Dollar-Fusion mit Bristol Myers

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

Astrazeneca explores $400bn megadeal with US rival

AstraZeneca in talks over £300bn mega-merger with US rival – reports

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

AstraZeneca, BMS discuss $400B pharma mega-deal

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’

Ft: «AstraZeneca tratta con Bristol Myers Squibb per una maxi fusione da 400 miliardi» - Lettera43

Insider: Mega-Fusion zwischen Astra Zeneca und Bristol Myers im Gespräch

Pharma: Mega-Fusion zwischen Astra Zeneca und Bristol Myers im Gespräch